flu, RSV and COVID
GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...
While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...
In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
So she was delighted when, last year, health authorities in the US and Europe approved the first vaccines for respiratory syncytial virus. RSV vaccines hold the potential to reduce the thousands ...